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Introduction

Reported cases of hypercalcemia from silicone-induced granulomas
2
have been increasing over the last decade.
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Hypercalcemia

• Hypercalcemia from cosmetic surgery is a rare but potentially
emerging cause of delirium.
• We present a case of hypoactive delirium from hypercalcemia
secondary to granulomatous reaction to silicone injections.

Case Presentation

• Patient was a 39-year-old Hispanic woman with history of gluteal
silicone injections 20 years prior.
• She presented with gastrointestinal symptoms, cachexia, anorexia,
withdrawn behavior, and dysphoric affect.
• Psychiatry was consulted to evaluate for possible depression and
eating disorder.
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• On exam, she was dysphoric, lethargic, and confused with waxing
and waning alertness.
• She denied any psychiatric history and was reluctant to discuss
psychological matters.
• She denied symptoms meeting criteria for MDD, eating disorder, and
body dysmorphic disorder.
•E
 EG revealed encephalopathy.
• Calcium, calcitriol, and
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her silicone injections.
• She was diagnosed with hypoactive delirium secondary to
hypercalcemia from silicone-induced granulomas.
• Aripiprazole was initiated to improve mentation, mood, and energy to
good effect.
• However, she became noncompliant as she denied needing
psychotropic medications.
• Her calcium levels remained high (12.6, ionized 1.59), and her cachexia
worsened over time.
• Although medically unstable with persisting delirium, she was
brought home by family against medical advice.

Discussion

• Silicone-induced granulomas is an unusual but rising cause of hypercalcemia.
• Unfortunately, treatment is often difficult and noncurative.
2
Mainstay treatment with fluids and steroids temporarily improves hypercalcemia.
4
Excising the granulomas often fails as granulomas migrate.
• Both medical and surgical treatments were unsuccessful for our patient.
• Studies show that neuropsychiatric disturbances may persist even when
3
1
hypercalcemia resolves, but aripiprazole may improve hypoactive delirium as
briefly seen in our patient.

Conclusion

• Cases of granulomatous reactions to silicone injections are rare but increasing.
• Therefore, all CL psychiatrists should consider hypercalcemia from granulomatous
reactions in patients with prior cosmetic surgeries presenting with altered
mentation.
• Although delirium can persist after correcting hypercalcemia, aripiprazole may be
used supportively for hypoactive delirium.
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